Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), LCK inhibitors(Tyrosine-protein kinase LCK inhibitors), SRC inhibitors(Tyrosine-protein kinase SRC inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | CH | - |